Bladder cancer, version 3.2020, NCCN clinical practice guidelines in oncology TW Flaig, PE Spiess, N Agarwal, R Bangs, SA Boorjian, ... Journal of the National Comprehensive Cancer Network 18 (3), 329-354, 2020 | 512 | 2020 |
Randomized trial of hypofractionated external-beam radiotherapy for prostate cancer A Pollack, G Walker, EM Horwitz, R Price, S Feigenberg, AA Konski, ... Journal of Clinical Oncology 31 (31), 3860, 2013 | 504 | 2013 |
RTOG GU radiation oncology specialists reach consensus on pelvic lymph node volumes for high-risk prostate cancer CAF Lawton, J Michalski, I El-Naqa, MK Buyyounouski, WR Lee, ... International Journal of Radiation Oncology* Biology* Physics 74 (2), 383-387, 2009 | 431 | 2009 |
Development of RTOG consensus guidelines for the definition of the clinical target volume for postoperative conformal radiation therapy for prostate cancer JM Michalski, C Lawton, I El Naqa, M Ritter, E O'Meara, MJ Seider, ... International Journal of Radiation Oncology* Biology* Physics 76 (2), 361-368, 2010 | 415 | 2010 |
Prostate cancer–major changes in the American Joint Committee on Cancer eighth edition cancer staging manual MK Buyyounouski, PL Choyke, JK McKenney, O Sartor, HM Sandler, ... CA: a cancer journal for clinicians 67 (3), 245-253, 2017 | 412 | 2017 |
Long‐term survival after radical prostatectomy versus external‐beam radiotherapy for patients with high‐risk prostate cancer SA Boorjian, RJ Karnes, R Viterbo, LJ Rangel, EJ Bergstralh, EM Horwitz, ... Cancer 117 (13), 2883-2891, 2011 | 327 | 2011 |
A phase 3 trial of whole brain radiation therapy and stereotactic radiosurgery alone versus WBRT and SRS with temozolomide or erlotinib for non-small cell lung cancer and 1 to … PW Sperduto, M Wang, HI Robins, MC Schell, M Werner-Wasik, R Komaki, ... International Journal of Radiation Oncology* Biology* Physics 85 (5), 1312-1318, 2013 | 324 | 2013 |
An evidence based review of proton beam therapy: the report of ASTRO’s emerging technology committee AM Allen, T Pawlicki, L Dong, E Fourkal, M Buyyounouski, K Cengel, ... Radiotherapy and Oncology 103 (1), 8-11, 2012 | 300 | 2012 |
Dosimetry and preliminary acute toxicity in the first 100 men treated for prostate cancer on a randomized hypofractionation dose escalation trial A Pollack, AL Hanlon, EM Horwitz, SJ Feigenberg, AA Konski, B Movsas, ... International Journal of Radiation Oncology* Biology* Physics 64 (2), 518-526, 2006 | 293 | 2006 |
Long-term outcomes of stereotactic body radiotherapy for low-risk and intermediate-risk prostate cancer AU Kishan, A Dang, AJ Katz, CA Mantz, SP Collins, N Aghdam, FI Chu, ... JAMA network open 2 (2), e188006-e188006, 2019 | 261 | 2019 |
Bladder cancer, version 5.2017, NCCN clinical practice guidelines in oncology PE Spiess, N Agarwal, R Bangs, SA Boorjian, MK Buyyounouski, ... Journal of the National Comprehensive Cancer Network 15 (10), 1240-1267, 2017 | 248 | 2017 |
NCCN guidelines insights: bladder cancer, version 5.2018 TW Flaig, PE Spiess, N Agarwal, R Bangs, SA Boorjian, ... Journal of the national comprehensive cancer network 16 (9), 1041-1053, 2018 | 241 | 2018 |
Microvessel density in prostate cancer: lack of correlation with tumor grade, pathologic stage, and clinical outcome MA Rubin, M Buyyounouski, E Bagiella, S Sharir, A Neugut, M Benson, ... Urology 53 (3), 542-547, 1999 | 201 | 1999 |
The Phoenix definition of biochemical failure predicts for overall survival in patients with prostate cancer MC Abramowitz, T Li, MK Buyyounouski, E Ross, RG Uzzo, A Pollack, ... Cancer: Interdisciplinary International Journal of the American Cancer …, 2008 | 197 | 2008 |
What dose of external-beam radiation is high enough for prostate cancer? TN Eade, AL Hanlon, EM Horwitz, MK Buyyounouski, GE Hanks, ... International Journal of Radiation Oncology* Biology* Physics 68 (3), 682-689, 2007 | 195 | 2007 |
Hypofractionated radiation therapy for localized prostate cancer: executive summary of an ASTRO, ASCO, and AUA evidence-based guideline SC Morgan, K Hoffman, DA Loblaw, MK Buyyounouski, C Patton, ... Practical radiation oncology 8 (6), 354-360, 2018 | 191 | 2018 |
Hypofractionated radiation therapy for localized prostate cancer: An ASTRO, ASCO, and AUA evidence-based guideline SC Morgan, K Hoffman, DA Loblaw, MK Buyyounouski, C Patton, ... Journal of Clinical Oncology 36 (34), 3411, 2018 | 177 | 2018 |
Transurethral surgery and twice-daily radiation plus paclitaxel-cisplatin or fluorouracil-cisplatin with selective bladder preservation and adjuvant chemotherapy for patients … T Mitin, D Hunt, WU Shipley, DS Kaufman, R Uzzo, CL Wu, ... The lancet oncology 14 (9), 863-872, 2013 | 165 | 2013 |
NCCN Guidelines® insights: bladder cancer, version 2.2022: featured updates to the NCCN guidelines TW Flaig, PE Spiess, M Abern, N Agarwal, R Bangs, SA Boorjian, ... Journal of the National Comprehensive Cancer Network 20 (8), 866-878, 2022 | 141 | 2022 |
Prostate cancer classification with multiparametric MRI transfer learning model Y Yuan, W Qin, M Buyyounouski, B Ibragimov, S Hancock, B Han, L Xing Medical physics 46 (2), 756-765, 2019 | 123 | 2019 |